IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.

Patients receiving ICIs were associated with a greater risk of developing RA, but lower risks for SLE and SSc.

Axial involvement is present in approximately 25% of patients with PsA, with enthesitis, inflammatory bowel disease, and ...

Patients with hidradenitis suppurativa are at increased risk of developing several common inflammatory arthropathies in the years following diagnosis.

The TYK2 inhibitor deucravacitinib (Sotyktu) showed clinical potential in two diseases other than psoriasis, according to ...

Bristol-Myers Squibb (BMY) stock in focus as psoriasis drug Sotyktu shows promising results in treating psoriatic arthritis ...

Rebecca Haberman, MD, of NYU Langone Health, highlights precision medicine and potential prevention strategies, two areas of promising psoriatic arthritis research. What are the most promising ...

Methotrexate (MTX) is a drug that has been used to treat psoriatic arthritis (PsA) for more than 40 years. Alone or in combination with other therapies, MTX is considered a first-line treatment ...

Speaking to Jonathan about the science behind arthritis, she shared a diet that can reduce inflammation, improve mobility, and "shield you from the threat of this disease." The health expert also ...

The authors tested CBD on rheumatoid arthritis synovial fibroblasts (RASFs), a type of cell within certain connective tissue forms, such as the synovium, which lines a person’s joints.